Skip to content

An Exploratory RCT of a Psychosocial Group Intervention for Epilepsy

An Exploratory Randomised Controlled Trial of a Manualised Psychosocial Group Intervention for Young People With Epilepsy (PIE)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02349529
Acronym
PIE
Enrollment
200
Registered
2015-01-29
Start date
2015-02-28
Completion date
2016-04-30
Last updated
2015-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Keywords

Epilepsy, psychosocial

Brief summary

Children and young people with epilepsy are at increased risk of poorer outcomes related to emotional and psychological adjustment, peer relationship problems, lower academic attainment and mental health problems across the lifespan. Despite the well understood risks, there continues to be a lack of psychological and psychosocial support for young people with epilepsy, and a corresponding lack of evidence regarding the effectiveness of psychosocial interventions. This study aims to evaluate a manualised psychosocial group intervention for adolescents with epilepsy. A cognitive behaviour therapy approach is used, aimed at increasing awareness of how epilepsy may impact upon thoughts, feelings and activities and to develop strategies for improved psychological adjustment. In addition, an epilepsy knowledge component aimed at improving a sense of control and epilepsy self-management is included. A group delivery format allows an opportunity for social modelling, and social problem solving, helping others and relating to other young people with similar experiences. The social learning context and availability of knowledgable facilitators (an epilepsy nurse specialist and clinical psychologist) are also key aspects of the intervention. The study will allow us to establish a standard manualised group intervention that can be used throughout the UK which aims to; establish the effectiveness and desirability of this approach; improve the overall quality of life, psychological health and social integration of young people with epilepsy; and to improve epilepsy knowledge and selfmanagement skills aimed at maximising seizure control and overall management.

Interventions

6 group sessions

Treatment as usual

Sponsors

NHS Greater Glasgow and Clyde
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Written informed consent * Diagnosis of epilepsy (controlled or refractory) of at least 6 months duration * Between the ages of 1217 years old * Have a reasonable level of expressive and receptive English language abilities to enable them to fully participate and contribute to the group process * In mainstream schooling.

Exclusion criteria

* Formal diagnosis of Learning Disability or attendance at a school for children with Special Educational Needs * Complex and severe mental health problems; * Diagnosis of nonepileptic seizures in the absence of epileptic seizures * Epilepsies occurring in the context of: 1. Postnatally acquired structural lesions (e.g. TBI or neurooncological conditions) 2. Immune mediated disorders (e.g. limbic or antiNMDAR encephalopathy) 3. Metabolic disorders (e.g. GLUT1 deficiency)

Design outcomes

Primary

MeasureTime frameDescription
Effectiveness of the PIE groupBaselineComparing participant's quality of life at baseline, completion of intervention, and at 3 and 6 month post group completion, as measured via the GEOSYP and PedsQL

Secondary

MeasureTime frame
The Seizure Self Efficacy Scale for Children (SSEC)Baseline, 6 weeks, 3 months and 6 months
Epilepsy Knowledge ProfileGeneral (EKPG)Baseline, 6 weeks, 3 months and 6 months
The Paediatric Index of Emotional Distress (PIED).Baseline, 6 weeks, 3 months and 6 months
Participant social functioningBaseline, 6 weeks, 3 months and 6 months
seizure controlBaseline, 6 weeks, 3 months and 6 months
Brief Illness Representations Questionnaire (BIPQ).Baseline, 6 weeks, 3 months and 6 months

Contacts

Primary ContactLiam Dorris, BSc (Hons), D.Clin.Psy
liam.dorris@ggc.scot.nhs.uk01412010638
Backup ContactHelen Broome, BSc (Hons), D.Clin.Psy
helen.broome@ggc.scot.nhs.uk01412010638

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026